ATE430730T1 - Phenyl-substituierte indole als h3 histaminrezeptorantagonisten - Google Patents
Phenyl-substituierte indole als h3 histaminrezeptorantagonistenInfo
- Publication number
- ATE430730T1 ATE430730T1 AT01920898T AT01920898T ATE430730T1 AT E430730 T1 ATE430730 T1 AT E430730T1 AT 01920898 T AT01920898 T AT 01920898T AT 01920898 T AT01920898 T AT 01920898T AT E430730 T1 ATE430730 T1 AT E430730T1
- Authority
- AT
- Austria
- Prior art keywords
- phenyl
- receptor antagonists
- histamine receptor
- substituted indoles
- substituted
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 229940122236 Histamine receptor antagonist Drugs 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19407100P | 2000-03-31 | 2000-03-31 | |
| US27228701P | 2001-02-28 | 2001-02-28 | |
| PCT/US2001/010320 WO2001074773A2 (en) | 2000-03-31 | 2001-03-29 | Phenyl-substituted indoles as histamine h3-receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE430730T1 true ATE430730T1 (de) | 2009-05-15 |
Family
ID=26889668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01920898T ATE430730T1 (de) | 2000-03-31 | 2001-03-29 | Phenyl-substituierte indole als h3 histaminrezeptorantagonisten |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1268421B1 (de) |
| AT (1) | ATE430730T1 (de) |
| AU (1) | AU2001247906A1 (de) |
| DE (1) | DE60138605D1 (de) |
| ES (1) | ES2325477T3 (de) |
| WO (1) | WO2001074773A2 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208497B2 (en) | 2001-07-02 | 2007-04-24 | Novo Nordisk A/S | Substituted piperazines and diazepanes |
| ATE479655T1 (de) | 2001-09-14 | 2010-09-15 | High Point Pharmaceuticals Llc | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative |
| US6673829B2 (en) | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
| US7645756B2 (en) * | 2004-02-18 | 2010-01-12 | Banyu Pharmaceutical Co. Ltd. | Nitrogenous fused heteroaromatic ring derivative |
| PL1761519T3 (pl) | 2004-06-21 | 2008-09-30 | Hoffmann La Roche | Pochodne indolu jako antagoniści receptorów histaminowych |
| KR100841838B1 (ko) * | 2004-06-21 | 2008-06-27 | 에프. 호프만-라 로슈 아게 | 히스타민 수용체 길항제로서의 인돌 유도체 |
| EP1771169A1 (de) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Verfahren zur behandlung von hepatitis c |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| JP2008507518A (ja) | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎を治療するためのチエノピリジン |
| WO2006077024A2 (en) * | 2005-01-19 | 2006-07-27 | F. Hoffmann-La Roche Ag | 5-aminoindole derivatives |
| EP1717235A3 (de) * | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidine und -pyrrolidine und ihre Verwendung als Liganden für den Histamin H3-Rezeptor |
| CA2614116A1 (en) | 2005-07-04 | 2007-01-11 | Novo Nordisk A/S | Novel medicaments |
| AR056690A1 (es) * | 2005-10-14 | 2007-10-17 | Athersys Inc | Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc |
| ES2342979T3 (es) * | 2005-11-30 | 2010-07-20 | F. Hoffmann-La Roche Ag | Derivados de indol-2-carboxamida sustituidos en 5. |
| AU2007227681A1 (en) | 2006-03-15 | 2007-09-27 | Wyeth | N-substituted-azacyclylamines as histamine-3 antagonists |
| CA2645581A1 (en) | 2006-03-28 | 2007-10-04 | High Point Pharmaceuticals, Llc | Benzothiazoles having histamine h3 receptor activity |
| US7432255B2 (en) | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
| JP2009537542A (ja) | 2006-05-19 | 2009-10-29 | ワイス | ヒスタミン−３アンタゴニストとしてのｎ−ベンゾイルピロリジン−３−イルアミンおよびｎ−ベンジルピロリジン−３−イルアミン |
| SI2079732T1 (sl) | 2006-05-29 | 2012-03-30 | High Point Pharmaceuticals Llc | benzodioksol il ciklopropilpiperazin il piridazin njegove soli in solvati in njegova uporaba kot antagonist histaminskega receptorja H |
| PE20081152A1 (es) | 2006-10-06 | 2008-08-10 | Wyeth Corp | Azaciclilaminas n-sustituidas como antagonistas de histamina-3 |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| US7557108B2 (en) * | 2007-02-07 | 2009-07-07 | Hoffmann-La Roche Inc. | (Indol-4-yl) or (indol-5-yl)-piperazinylmethanones |
| EP2014656A3 (de) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | Neue heterocyclische H3-Antagonisten |
| CL2008002088A1 (es) | 2007-07-16 | 2008-09-05 | Wyeth Corp | Compuestos derivados de fenilo sustituido, moduladores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de trastornos cognitivos tales como demencia, alzheimer, entre otros. |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US338106A (en) * | 1886-03-16 | Victor roper | ||
| US5385912A (en) * | 1991-03-08 | 1995-01-31 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| US5681954A (en) * | 1993-05-14 | 1997-10-28 | Daiichi Pharmaceutical Co., Ltd. | Piperazine derivatives |
| JP2000516611A (ja) * | 1996-08-14 | 2000-12-12 | ワーナー―ランバート・コンパニー | Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体 |
| US6172100B1 (en) * | 1997-04-30 | 2001-01-09 | Eli Lilly And Company | Antithrombotic agents |
| WO1999033822A1 (en) * | 1997-12-24 | 1999-07-08 | Smithkline Beecham Laboratoires Pharmaceutiques | Indole derivatives useful a.o. for the treatment of osteoporosis |
-
2001
- 2001-03-29 AU AU2001247906A patent/AU2001247906A1/en not_active Abandoned
- 2001-03-29 ES ES01920898T patent/ES2325477T3/es not_active Expired - Lifetime
- 2001-03-29 WO PCT/US2001/010320 patent/WO2001074773A2/en not_active Ceased
- 2001-03-29 DE DE60138605T patent/DE60138605D1/de not_active Expired - Lifetime
- 2001-03-29 AT AT01920898T patent/ATE430730T1/de not_active IP Right Cessation
- 2001-03-29 EP EP01920898A patent/EP1268421B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001074773A3 (en) | 2002-04-04 |
| WO2001074773A2 (en) | 2001-10-11 |
| EP1268421A2 (de) | 2003-01-02 |
| DE60138605D1 (de) | 2009-06-18 |
| AU2001247906A1 (en) | 2001-10-15 |
| EP1268421B1 (de) | 2009-05-06 |
| ES2325477T3 (es) | 2009-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE430730T1 (de) | Phenyl-substituierte indole als h3 histaminrezeptorantagonisten | |
| WO2001074815A3 (en) | Phenyl-substituted imidazopyridines | |
| DK1773885T3 (da) | Humaniserede anti-c-met-antagonister | |
| ATE501118T1 (de) | Substituierte indole | |
| NO20051337L (no) | Indol- eller benzimidazolderivater for modulering av ikB-kinase. | |
| DE50209929D1 (de) | Substituierte cyclohexan-1,4-diaminderivate | |
| ATE344030T1 (de) | 4-piperazinylbenzolsulfonyl-indole mit 5-ht6 rezeptor-affinität | |
| DE69929235D1 (de) | Spiro-indole als y5-rezeptor antagonisten | |
| ATE340792T1 (de) | Substituierte indole als alpha-1 agonisten | |
| CY1112017T1 (el) | Πολυμορφικες μορφες 3-(4-αμινο-1-οξο-1,3-διϋδρο-ισοϊνδολ-2-υλ)-πιπεριδινο-2,6-διονης | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| DK1265615T3 (da) | Ny kombination af ikkesederende antihistaminika med substanser, der påvirker leukotrien-virkningen, til behandling af rhinitis/conjunctivtis | |
| NO20052909L (no) | Tetracyclic 3-substituted indoles having serotonin receptor affinity. | |
| NO20034130D0 (no) | Benzimidazolderivater som modulerer kjemokinreseptor | |
| ATE492535T1 (de) | 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren | |
| HRP20041224A2 (en) | Cck-1 receptor modulators | |
| DE60101906D1 (de) | Phenyl-substituierte indolizinderivate und deren verwendung als histamin h3 liganden | |
| NO20033223L (no) | Histamin-reseptor antagonister | |
| DE60205213D1 (de) | Substituierte indoline als 5-ht-rezeptor liganden | |
| CY1113926T1 (el) | Μεθοδος κατασκευης πολυμορφικων μορφων 3-(4-αμινο-1-οξο-1,3-διϋδρο-ισοϊνδολ-2-υλ)-πιπεριδινο-2,6-διονης | |
| BR0002142A (pt) | Inibidores de quinase myti | |
| TR200001286A2 (tr) | MYT 1 kinaz inhibitörleri | |
| BR0202090B1 (pt) | composição seca de argamassa contendo cimento, e, argamassa contendo cimento. | |
| ES1043861Y (es) | Fregadero perfeccionado. | |
| DOP2001000306A (es) | Derivados de indol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |